Beyond lysosomal disorders, dysregulation of UGCG, the rate-limiting enzyme for GlcCer biosynthesis, is frequently observed across multiple malignancies and strongly correlates with tumor progression, metastatic potential, and multidrug resistance [75]. This evidence concerns the gene UGCG and neoplasm.